SelectQuote Inc (SLQT) is an excellent investment, but the stock is overvalued/undervalued right now

While SelectQuote Inc has overperformed by 0.79%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, SLQT fell by -31.72%, with highs and lows ranging from $6.86 to $1.62, whereas the simple moving average fell by -16.89% in the last 200 days.

On May 21, 2025, Jefferies started tracking SelectQuote Inc (NYSE: SLQT) recommending Hold. A report published by Craig Hallum on September 30, 2024, Initiated its previous ‘Buy’ rating for SLQT. Noble Capital Markets also rated SLQT shares as ‘Outperform’, setting a target price of $5 on the company’s shares in an initiating report dated February 29, 2024. Credit Suisse Initiated an Neutral rating on April 01, 2022, and assigned a price target of $4. RBC Capital Mkts resumed its ‘Sector Perform’ rating for SLQT, as published in its report on February 08, 2022. Barclays’s report from February 08, 2022 suggests a price prediction of $5 for SLQT shares, giving the stock a ‘Equal Weight’ rating. Piper Sandler also rated the stock as ‘Neutral’.

Analysis of SelectQuote Inc (SLQT)

Further, the quarter-over-quarter increase in sales is 8.44%, showing a positive trend in the upcoming months.

One of the most important indicators of SelectQuote Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of 0.82% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.86, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

For any stock, average volume can also provide valuable insight into volatility, and SLQT is recording 1.30M average volume. On a monthly basis, the volatility of the stock is set at 4.66%, whereas on a weekly basis, it is put at 6.27%, with a gain of 1.60% over the past seven days. Furthermore, long-term investors anticipate a median target price of $5.69, showing growth from the present price of $2.54, which can serve as yet another indication of whether SLQT is worth investing in or should be passed over.

How Do You Analyze SelectQuote Inc Shares?

Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 21.44%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 41.66% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

SLQT shares are owned by institutional investors to the tune of 41.66% at present.

Hot this week

What to expect from CRWD’s earnings report this quarter?

In the current trading session, Crowdstrike Holdings Inc's (CRWD)...

Predicting Inmode Ltd’s (INMD) earnings for the current quarter

Inmode Ltd (INMD)'s stock is trading at $15.46 at...

BKD’s Q2 earnings predictions: What the experts say

Brookdale Senior Living Inc (BKD)'s stock has witnessed a...

How will IGC Pharma Inc’s (IGC) earnings compare to estimates this quarter?

Currently, IGC Pharma Inc's (IGC) stock is trading at...

DVN’s Q2 earnings estimates: What investors need to know

In the current trading session, Devon Energy Corp's (DVN)...

Topics

What to expect from CRWD’s earnings report this quarter?

In the current trading session, Crowdstrike Holdings Inc's (CRWD)...

Predicting Inmode Ltd’s (INMD) earnings for the current quarter

Inmode Ltd (INMD)'s stock is trading at $15.46 at...

BKD’s Q2 earnings predictions: What the experts say

Brookdale Senior Living Inc (BKD)'s stock has witnessed a...

How will IGC Pharma Inc’s (IGC) earnings compare to estimates this quarter?

Currently, IGC Pharma Inc's (IGC) stock is trading at...

DVN’s Q2 earnings estimates: What investors need to know

In the current trading session, Devon Energy Corp's (DVN)...

Can Frontline Plc (FRO) meet market expectations this quarter?

Frontline Plc (FRO)'s stock is trading at $18.27 at...

BBIO’s earnings forecast for the current quarter

BridgeBio Pharma Inc (BBIO)'s stock has witnessed a price...

Breaking down XERS’s current quarter earnings estimates

Currently, Xeris Biopharma Holdings Inc's (XERS) stock is trading...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.